Overview
- 49 inspections across 48 sites are on record.
- 33 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-18.
At a glance
Inspections
49
Sites
48
Observations
33
Career since
Apr 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Sherif M. El-Harazi, M.D., MPH | 18 Jun 2026 | Human Drugs | |
| Doris V. Quon, M.D. | 13 May 2026 | Biologics | |
| Sargon Lazarof, DDS | 1 May 2026 | Medical Devices & Rad Health | View 483 → |
| Jonathan W. Goldman, MD | 9 Apr 2026 | Human Drugs | |
| Paul W. Wallace, MD | 17 Mar 2026 | Human Drugs | View 483 → |
Sites inspected
Sherif M. El-Harazi, M.D., MPHGlendale, United States1 insp.
Doris V. Quon, M.D.Los Angeles, United States1 insp.
Sargon Lazarof, DDSEncino, United States1 insp.
Jonathan W. Goldman, MDSanta Monica, United States1 insp.
Paul W. Wallace, MDLos Angeles, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Jose A Leyva6 shared
Raman K Kaushal4 shared
Korina Serrano2 shared
Cheron M Portee2 shared
Habacuc V Barrera2 shared
Colleen E Burke2 shared
Grace P Santos2 shared
Bruno Baltazar1 shared
Michelle S Anantha1 shared
Farwa Z Razvi1 shared
Full investigator report
Get the verbatim findings behind Jasmine Y Wang's 33 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site